Co-CEO Andrew Bialecki sold 212,529 shares of KVYO at $14.61 via scheduled 10b5-1 plan; stock down 26.1% in 30 days.
Andrew Bialecki, Co-Chief Executive Officer, sold 212,529 shares at $14.61 on 2026-05-26 under a pre-arranged 10b5-1 trading plan adopted on 2025-05-20, meaning this was a scheduled transaction rather than discretionary timing. The sale occurred as the stock trades at $14.74 current price, down 59.9% from its 52-week high and off 26.1% over the prior 30 days. His prior five trades at KVYO have averaged negative 30-day and 90-day returns, ranging from -1.7% to -17.5% in the 30-day window. Klaviyo reported latest-quarter revenue of $358,005,000.00 with annual revenue growth of 31.6%, but the company was unprofitable over its most recent full fiscal year, creating a divergence between growth trajectory and current profitability that warrants attention to the fundamentals underlying the stock's recent weakness.
Co-CEO Bialecki sells entire 200.0K share stake in KVYO for $2,976,000.00 via 10b5-1 plan; stock down -24.7% in 30 days.
Bialecki Andrew, Co-Chief Executive Officer, executed a complete liquidation of his 200,000 share position at $14.88 per share on 2026-05-19, reducing holdings from 200.0K shares to 0 shares. This transaction is scheduled under a 10b5-1 trading plan adopted on 2025-05-20 and is not discretionary. The stock has declined -24.7% over the 30 days following the sale and stands at $15.11, down -58.9% from the 52-week high of $36.76. His prior five sales at KVYO show mixed post-transaction performance, with 30-day returns ranging from -18.1% to +3.4%, while his cross-ticker track record across 20 prior sells shows an average 90-day return of -23.7%. The company posted $358.0M in revenue (latest quarter) with +31.6% annual revenue growth, though it remains unprofitable on a full-year basis with negative net income.
Klaviyo Co-CEO Bialecki sells 200.0K shares in 2 transactions for $2.9M, reducing holdings to 0 under 10b5-1 plan
Co-Chief Executive Officer Andrew Bialecki executed 2 separate sales totaling 200,000 shares for $2,921,928.84 under a 10b5-1 trading plan adopted on 2025-05-20, leaving him with 0 shares post-transaction — a -100.0% reduction from his pre-transaction holdings of 200,000 shares. Because this is a scheduled transaction, the execution timing relative to price action is not a property of this trade. The stock currently sits at $14.34, down -62.0% from its 52-week high and -15.4% over 30 days and -22.9% over 90 days, context that reflects market conditions at the time of plan execution but not discretionary judgment. On the fundamentals side, Klaviyo reported latest-quarter revenue of $358.0M and net income of $9.0M, though the company was unprofitable over its most recent full fiscal year.
Add KVYO to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
